Regulation of CR2/CD21 Expression and Activation
Regulation of CR2/CD21 Expression and Activation
批准号:
7880369
负责人:
John Weis
金额:
$1.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-11 至 2010-09-30
关键词:
AnimalsAntigensB cell differentiationB-Lymphocyte SubsetsB-LymphocytesBindingBiological AssayBiological ModelsCD19 geneCell SurvivalCellsComplement 3d ReceptorsComplement ReceptorDefectElementsEngineeringEnvironmentFollicular Dendritic CellsGenerationsGenesGoalsHealthHerpesviridaeImmuneImmune responseImmunoglobulin IsotypesImmunologic MemoryIndividualInfectionInflammation MediatorsLigand BindingMediator of activation proteinMolecularMusMutant Strains MiceMutationPathway interactionsPopulationPositioning AttributeProteinsReceptor SignalingRegulationRegulator GenesRegulatory ElementRoleSignal PathwaySignal TransductionSiteSpleenStagingStructure of germinal center of lymph nodeTimeTranscription CoactivatorTranscriptional RegulationVirus Diseasescomparativedepresseddesignnovelpromoterreceptorresearch studyresponsetranscription factor
中文摘要
小鼠CD21/Cr2基因编码两种与获得最佳免疫有关的蛋白质
回应。CD21途径包括B细胞存活和最佳激活的信号,以及
位于脾生发中心的滤泡树突状细胞(FDC)产生的天然抗原。的表达方式
小鼠CD21受到严格控制。这些蛋白质是在B细胞分化的特定阶段发现的
一旦它们在脾内就位,FDC就会表达它们。
这项相互竞争的申请建议继续我们对CD21基因控制机制的分析
以及CD21蛋白在产生适当的免疫反应中的功能。我们有
证实了启动子和内含子元件调控CD21基因。我们建议继续我们的
分析CD21的转录控制,结合另外两个基因的比较分析,
CD19和CD23,在B细胞分化的相似时间表达。我们还将继续我们的
对CD21内含子控制区基因工程缺失的突变小鼠品系的检查。这些
分析还包括疱疹病毒转录激活物诱导CD21和CD23的作用
表达,以及这种过度表达对免疫反应的影响。
我们对CD21蛋白功能的分析将集中在CD21蛋白作为
补体受体增强获得性和先天免疫反应
免疫球蛋白亚型。我们还将分析各种基因产物的作用,这些基因产物表达的
CD21缺陷动物在免疫激活过程中发生严重变化。
产生适当的免疫反应对个体的健康至关重要。CD21
蛋白质跨越获得性和先天免疫反应领域,因此它们的操纵可以
影响对感染的即时反应以及免疫学更长期的后果
记忆。
英文摘要
The murine CD21/Cr2 gene encodes two proteins implicated in the acquisition of an optimal immune
response. The CD21 pathway includes signals for B cell survival and optimal activation, and presentation of
native antigen by follicular dendritic cells (FDC) in the germinal centers of the spleen. The expression of
murine CD21 is tightly controlled. The proteins are found on B cells during specific stages of differentiation
and are expressed by FDC once they have taken up their position within the spleen.
This competing application proposes to continue our analysis of the mechanism of CD21 gene control
and the functions of the CD21 proteins in the generation of an appropriate immune response. We have
demonstrated that promoter and intronic elements regulate the CD21 gene. We propose to continue our
analysis of the transcriptional control of CD21, incorporating the comparative analysis of two other genes,
CD19 and CD23, that are expressed at similar times of B cell differentiation. We will also continue our
examination of a mutant mouse line with an engineered deletion of the CD21 intronic control region. These
analyses also include the role of transcriptional activators from herpes virus that induce CD21 and CD23
expression, and the effect of such over expression on the immune response.
Our analysis of the function of the CD21 proteins will focus upon the role of the CD21 proteins as
complement receptors enhancing both the acquired and innate immune responses including the generation
of the immunoglobulin isotypes. We will also analyze the role of various gene products whose expression is
critically altered in CD21 deficient animals during immune activation.
The generation of an appropriate immune response is critical to the health of the individual. The CD21
proteins straddle the fields of acquired and innate immune responses such that their manipulation could
influence immediate responses to an infection as well as the more long term consequences of immunologic
memory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Ifitm/Fragilis proteins as intracellular shuttles during cell activation
-
批准号:8043909
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2010
-
负责人:John Weis
-
依托单位:
Role of Ifitm/Fragilis proteins as intracellular shuttles during cell activation
-
批准号:8197848
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2010
-
负责人:John Weis
-
依托单位:
Role of the Fragilis Proteins in the Immune Response
-
批准号:6894009
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2004
-
负责人:John Weis
-
依托单位:
Role of the Fragilis Proteins in the Immune Response
-
批准号:6804271
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2004
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6631980
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
PACTOLUS AND MAST CELL AND MORROW CELL FUNCTION
-
批准号:2705528
-
项目类别:
-
资助金额:$19.68万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6886799
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6721189
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
PACTOLUS AND MAST CELL AND MORROW CELL FUNCTION
-
批准号:2887616
-
项目类别:
-
资助金额:$20.27万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6510757
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
PACTOLUS AND MAST CELL AND MORROW CELL FUNCTION
-
批准号:6170928
-
项目类别:
-
资助金额:$20.88万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6400854
-
项目类别:
-
资助金额:$30.38万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
CHARACTERIZATION OF MAST CELL INTEGRINS
-
批准号:2067907
-
项目类别:
-
资助金额:$12.15万
-
财政年份:1993
-
负责人:John Weis
-
依托单位:
CHARACTERIZATION OF MAST CELL INTEGRINS
-
批准号:3148049
-
项目类别:
-
资助金额:$12.06万
-
财政年份:1993
-
负责人:John Weis
-
依托单位:
CHARACTERIZATION OF MAST CELL INTEGRINS
-
批准号:2067908
-
项目类别:
-
资助金额:$14.27万
-
财政年份:1993
-
负责人:John Weis
-
依托单位:
MOLECULAR CHARACTERIZATION OF CR1 AND RELATED PROTEINS
-
批准号:3136915
-
项目类别:
-
资助金额:$4.01万
-
财政年份:1986
-
负责人:John Weis
-
依托单位:
CHARACTERIZATION OF THE MURINE COMPLEMENT RECEPTORS
-
批准号:3136917
-
项目类别:
-
资助金额:$18.9万
-
财政年份:1986
-
负责人:John Weis
-
依托单位:
MURINE COMPLEMENT RECEPTOR CR2
-
批准号:2871484
-
项目类别:
-
资助金额:$23.0万
-
财政年份:1986
-
负责人:John Weis
-
依托单位:
CHARACTERIZATION OF THE MURINE COMPLEMENT RECEPTORS
-
批准号:3136914
-
项目类别:
-
资助金额:$18.82万
-
财政年份:1986
-
负责人:John Weis
-
依托单位:
REGULATION OF CR2/CD21 EXPRESSION AND ACTIVATION
-
批准号:6288216
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1986
-
负责人:John Weis
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: